(IBTI) iShares iBonds Dec 2028 - Ratings and Ratios

Exchange: NASDAQ • Country: USA • Currency: USD • Type: Etf • ISIN: US46436E8333

Treasury,Bond,Fixed,Income,Maturity

Description: IBTI iShares iBonds Dec 2028

The iShares iBonds Dec2028 Term Treasury ETF (IBTI) is a target maturity ETF that tracks a specific segment of the US Treasury market, providing investors with a defined maturity schedule and a predictable income stream. As a Treasury ETF, its performance is closely tied to interest rates and the overall shape of the yield curve.

Key drivers of the funds performance include changes in US monetary policy, inflation expectations, and the overall demand for US Treasuries. The funds maturity profile, set to mature in December 2028, makes it sensitive to shifts in the yield curve, particularly in the 10-year to 15-year segment. As a result, investors should monitor the Federal Reserves actions, economic indicators such as GDP growth and inflation rates, and global events that impact US Treasury demand.

To evaluate the funds performance, investors can track key metrics such as yield to maturity, duration, and the funds tracking error relative to its benchmark. The funds yield to maturity is a critical KPI, as it reflects the total return an investor can expect if they hold the fund until maturity. Additionally, the funds duration, which measures its sensitivity to interest rate changes, is essential in assessing potential price volatility.

The funds assets under management (AUM) of $1.082 billion indicate a moderate level of investor interest. As a relatively liquid ETF, with an average trading volume of 155,300 shares, investors can enter or exit positions with relative ease. However, investors should remain aware of potential liquidity risks, particularly during periods of market stress.

To make informed investment decisions, investors should consider the funds characteristics, such as its maturity profile, yield, and duration, in the context of their overall investment objectives and risk tolerance. By doing so, they can effectively utilize IBTI as a component of a broader investment strategy, potentially benefiting from the funds predictable income stream and relatively low credit risk.

IBTI ETF Overview

Market Cap in USD 1,088m
Category Target Maturity
TER 0.07%
IPO / Inception 2020-02-25

IBTI ETF Ratings

Growth Rating 40.2%
Fundamental -
Dividend Rating 75.1%
Return 12m vs S&P 500 -13.2%
Analyst Rating -

IBTI Dividends

Dividend Yield 12m 3.93%
Yield on Cost 5y 3.70%
Annual Growth 5y 42.54%
Payout Consistency 100.0%
Payout Ratio %

IBTI Growth Ratios

Growth Correlation 3m 91.3%
Growth Correlation 12m 87%
Growth Correlation 5y -37.5%
CAGR 5y 3.87%
CAGR/Max DD 3y 0.71
CAGR/Mean DD 3y 3.11
Sharpe Ratio 12m 0.10
Alpha -16.86
Beta 0.974
Volatility 2.79%
Current Volume 253.5k
Average Volume 20d 186.2k
Stop Loss 21.7 (-3.2%)
Signal 0.32

What is the price of IBTI shares?

As of September 16, 2025, the stock is trading at USD 22.42 with a total of 253,461 shares traded.
Over the past week, the price has changed by +0.02%, over one month by +0.87%, over three months by +2.16% and over the past year by +3.18%.

Is iShares iBonds Dec 2028 a good stock to buy?

Partly, yes. Based on ValueRay´s Analyses, iShares iBonds Dec 2028 (NASDAQ:IBTI) is currently (September 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 40.18 and therefor an somewhat technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of IBTI is around 21.33 USD . This means that IBTI is currently overvalued and has a potential downside of -4.86%.

Is IBTI a buy, sell or hold?

iShares iBonds Dec 2028 has no consensus analysts rating.

What are the forecasts/targets for the IBTI price?

Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 24 7.1%

Last update: 2025-09-06 04:40

IBTI Fundamental Data Overview

Market Cap USD = 1.09b (1.09b USD * 1.0 USD.USD)
CCE Cash And Equivalents = unknown
Revenue TTM is 0, using Net Income TTM 0.0 + Cost of Revenue 0.0 = 0.0 USD
Beta = 0.72
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 1.09b USD (1.09b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = none (FCF TTM 0.0 / Enterprise Value 1.09b)
FCF Margin = unknown (Revenue TTM is 0)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 1.09b / Book Value Of Equity 0.0)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default)
NOPAT = 0.0 (EBIT 0.0, no tax applied on loss)
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown Debt (none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = none (Debt none / FCF TTM 0.0)
Total Stockholder Equity = unknown
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity none)
RoCE = unknown (Ebit 0.0 / (Equity none + L.T.Debt none))
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, Ebit 0.0)
WACC = unknown (E(1.09b)/V(0.0) * Re(9.60%)) + (D(none)/V(0.0) * Rd(0.0%) * (1-Tc(0.21)))
Discount Rate = 9.60% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)

Additional Sources for IBTI ETF

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle